Jeremy Bender - 31 Dec 2022 Form 5 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
Chief Executive Officer, Director
Signature
/s/ Charles N. York II, Attorney-in-Fact
Issuer symbol
DAWN
Transactions as of
31 Dec 2022
Net transactions value
$0
Form type
5
Filing time
13 Feb 2023, 17:20:14 UTC
Previous filing
22 Dec 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DAWN Common Stock Gift $0 -281,574 -19% $0.000000 1,192,424 31 Mar 2022 Direct F1
transaction DAWN Common Stock Gift $0 +281,574 $0.000000 281,574 31 Mar 2022 See Footnote F1, F2
transaction DAWN Common Stock Gift $0 -281,574 -19% $0.000000 1,192,424 31 Mar 2022 Direct F1
transaction DAWN Common Stock Gift $0 +281,574 $0.000000 281,574 31 Mar 2022 See Footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's Common Stock that the Reporting Person transferred as a bona fide gift for no consideration.
F2 Represents shares held by The Jeremy Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement dated March 29, 2022 of which the Reporting Person is trustee.
F3 Represents shares held by The Melissa Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement dated March 29, 2022 of which the Reporting Person's spouse is trustee.